Literature DB >> 15172310

Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion.

James Tibballs1, Rodrigo Soto, Tara Bharucha.   

Abstract

Postoperative chylothorax compromises nutrition, immune function, coagulation, and fluid status. We report rapid short-term suppression of chylothorax by octreotide in an infant after surgery for complex congenital heart disease complicated by lymphangiectasia.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15172310     DOI： 10.1016/S0003-4975(03)01423-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  5 in total

1.  Successful treatment of neonatal chylothorax with octreotide.

Authors:  Seyedeh Fatemeh Khatami; Pouya Parvaresh
Journal:  Indian J Pediatr       Date:  2011-05-28       Impact factor: 1.967

Review 2.  Surgical chylothorax in neonates: management and outcomes.

Authors:  Karina Miura Costa; Amulya Kumar Saxena
Journal:  World J Pediatr       Date:  2018-03-05       Impact factor: 2.764

3.  Octreotide in the treatment of neonatal postoperative chylothorax: report of three cases and literature review.

Authors:  João Moreira-Pinto; Paula Rocha; Angélica Osório; Berta Bonet; Fátima Carvalho; Carlos Duarte; Luísa Oliveira
Journal:  Pediatr Surg Int       Date:  2010-09-07       Impact factor: 1.827

Review 4.  Octreotide for Acquired Chylothorax in Pediatric Patients Post-Cardiothoracic Surgery for Congenital Heart Disease: A Systematic Review.

Authors:  A C Jenkinson; J McGuinness; T Prendiville
Journal:  Pediatr Cardiol       Date:  2022-10-18       Impact factor: 1.838

Review 5.  Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.

Authors:  Charles C Roehr; Andreas Jung; Hans Proquitté; Oliver Blankenstein; Hannes Hammer; Kokila Lakhoo; Roland R Wauer
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.